First gene therapy drug proves a flop in the market – Engadget
Engadget |
First gene therapy drug proves a flop in the market
Engadget When UniQure launched the first commercial gene therapy drug, Glybera, it promised a minor revolution in medicine. By using custom viruses to deliver genes, it could reportedly cure a rare disease (lipoprotein lipase deficiency) with just one round of … |
